Inhibitory Antibodies & Fusion Protein
Product Number | Product Name | CAS RN | Molecular Formula | Application |
Ranibizumab | 347396-82-1 | |||
Matuzumab | 339186-68-4 | |||
CLN17635 | Aflibercept | 862111-32-8 | ||
CLN16497 | Adalimumab | 331731-18-1 | ||
CLN17634 | Atezolizumab | 1380723-44-3 | ||
CLN16506 | Eculizumab | 219685-50-4 | ||
CLN16489 | Bevacizumab | 216974-75-3 | ||
CLN16490 | Rituximab | 174722-31-7 | ||
C14291 | Trastuzumab | 180288-69-1 | C6470H10012N1726O2013S42 | Antineoplastic Agent |
C13458 | Cetuximab | 205923-56-4 | C6484H10042N1732O2023S36 | Antineoplastic Agent |
CLN13616 | Etanercept | 185243-69-0 | C2224H3475N621O698S36 |
Products
- Category
- Active Pharmaceutical Ingredients
- Pharmaceutical Intermediates
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies & Fusion Protein
- Bioactive Small Molecules
- Stable Isotope Labelled Compounds
- Cytokines
- Dye Reagents
- Drug Impurities & Metabolites
- Natural Products
- Building Blocks & Specialty Chemicals